GENE-TRAK PLANS MID-1995 LAUNCH OF GALILEO TUBERCULOSIS ASSAY
This article was originally published in The Gray Sheet
Executive Summary
GENE-TRAK PLANS MID-1995 LAUNCH OF GALILEO TUBERCULOSIS ASSAY, the first in a line of diagnostics under development by the firm to detect "a broad range of respiratory and sexually transmitted infectious diseases," the company said in a release. After finalizing the nucleic acid probe system's design, Gene-Trak plans to begin clinicals in support of a 510(k) submission for the tuberculosis test. The firm already has identified a number of sites for clinical trials of the product.